Modeling & Meta-Analysis; Real-World Evidence & Data Analytics
PharmD, MS, BCPS
Bethesda, United States
Shelby Corman is a Director in the Modeling and Meta-Analysis and Real-World Evidence Centers of Excellence, located in Pharmerit’s Bethesda, USA office. Her expertise includes cost-effectiveness and budget impact modeling, particularly in acute care settings and early in the drug development process; medical chart review studies; and AMCP and global value dossiers. Shelby has therapeutic experience in the following areas: oncology, infectious diseases, postsurgical pain, hemophilia, pulmonary diseases, solid organ transplant, and liver disease.
Prior to joining Pharmerit, Shelby worked in an academic health system, in Pittsburgh, Pennsylvania across a breadth of roles including formulary management, drug policy, and outcomes research. Shelby is active in ISPOR and teaches the applied health economic modeling course at the International and European Congresses each year. Shelby earned her PharmD degree from the University of Pittsburgh School of Pharmacy, followed by a pharmacy residency specializing in drug information, and a MS degree in Health Services Research.